March 12, 2010
 

Safety Review of Avandia (Rosiglitazone)


Safety Review of Avandia (Rosiglitazone)
Description: FDA offers advice to people who take the diabetes drug Avandia (rosiglitazone) while the agency continues to review data on possible heart-related risks associated with the drug.
Source: www.fda.gov

Subscribe to Posts [Atom]